Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B

The aim of this review is to outline emerging biomarkers that can serve as diagnostic tools to identify non-cirrhotic chronic hepatitis B (CHB) patients who could safely discontinue nucleos(t)ide analogues (NAs) before HBsAg loss. Regarding possible predictors of post-NAs outcomes, a number of studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Papatheodoridi, Margarita, Papatheodoridis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072769/
https://www.ncbi.nlm.nih.gov/pubmed/32093411
http://dx.doi.org/10.3390/cells9020493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072769/
https://www.ncbi.nlm.nih.gov/pubmed/32093411
http://dx.doi.org/10.3390/cells9020493

Ejemplares similares